- Test combines sensitivity with speed and is designed to be used in health care settings to aid with rapid diagnosis of COVID-19 - LumiraDx's microfluidic technology and innovative Point of Care (POC ...

The MarketWatch News Department was not involved in the creation of this content. InBios International Inc., a leading developer of diagnostic tests for emerging infectious diseases, announced today ...

CHICAGO--(BUSINESS WIRE)--BioGX, a global provider of easy molecular diagnostic solutions, announced the launch of a point-of-care (POC) CE-Marked, three gene multiplex COVID-19 test on its pixl ...

PASADENA, CA, USA, April 4, 2024 /EINPresswire.com/ -- OSANG Healthcare, a leading healthcare diagnostics company since 1996, has announced its Emergency Use ...

Toronto, Ontario--(Newsfile Corp. - June 23, 2022) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), developer of its smart-enabled AcuVid™ COVID-19 Rapid Antigen Saliva ...

In a recent Morbidity and Mortality Weekly Report (MMWR) published on the United States Center for Disease Control and Prevention (US-CDC) website, researchers summarized data self-reported by users ...

(RTTNews) - LumiraDx (LMDX), a diagnostics company said on Thursday that its latest SARS-CoV-2 & Flu A/B Antigen Test has bagged CE Marking, the European Union's mandatory conformity marking system to ...

For instance, if you only get a very faint line, it might be hard to know whether or not that means your results are positive. I know how that feels firsthand. After more than two years of evading ...

COVID-19 tests are in greater demand than ever, and new data about the Omicron variant can make picking and using different types of tests confusing. Molecular tests for COVID-19, like the "RT-PCR" ...

InBios International Inc., a leading developer of diagnostic tests for emerging infectious diseases, announced today that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) ...